Please Wait...

BioClinica Names David Peters New Chief Financial Officer

June 2, 2015

BioClinica®, Inc., a specialty clinical trials services and technology provider, today announced that David Peters, an accomplished senior finance and accounting executive, has been named Executive Vice President and Chief Financial Officer (CFO) and will be joining BioClinica on June 8, 2015.

Peters brings more than 25 years of financial and accounting experience with a focus in pharmaceutical services. "David has extensive and deep knowledge in all areas of finance, accounting and business operations and understands the specifics of our high growth and diverse business segments in both private and public markets, making him well-suited for the position," said BioClinica CE0 John Hubbard, Ph.D.

Peters has directed all facets of accounting, financial functions and strategy in global businesses and has successfully negotiated more than 20 strategic partnership agreements. He was most recently CFO at WCCT Global where he developed the strategic plan, successfully positioning the contract research organization for growth and investment.  Prior to this he was Senior Vice President of Commercial and Corporate Development and CFO of the Late Phase Clinical Group at inVentiv Health. Additionally Peters spent 15 years at ICON Clinical Research where he held the positions of Senior Vice President of Global Finance, Vice President of Finance North and South America, and Controller.

"BioClinica is a dynamic and fast-growing company and I look forward to contributing to its exceptional future," said Peters. Peters, a certified public accountant, earned a Bachelor of Science degree in accounting and information systems from Johnson & Wales University and completed post-graduate studies in business administration at Philadelphia University.

Peters replaces Executive Vice President and CFO Ted Kaminer, who is retiring after 12 years with the company. "A key member of our senior management team, Ted has made significant contributions to the success and substantial growth of our organization," Dr. Hubbard said. "Thanks to the efforts of Ted and his teams, we are well-positioned for the future." Kaminer will stay on with BioClinica during the transition through the end of July.

Follow BioClinica on the Trial Blazers blog at http://www.bioclinica.com/blog, and on Twitter at http://twitter.com/bioclinica.

About Bioclinica

Bioclinica is a global life science provider that utilizes science and technology to bring clarity to clinical trials – helping companies to develop new life-improving therapies more efficiently and safely. Successful clinical trials require the ability to see key details and uncover hidden insights, and Bioclinica's hundreds of experienced scientific, medical, and domain experts bring unmatched insight across the development lifecycle, from the initial protocol to post-approval. The company's cloud-based offerings include medical imaging and cardiac safety services; clinical adjudication; randomization and trial supply management and optimization; electronic and eSource data capture; site and patient payments and budget forecasting; pharmacovigilance; trial management; and risk-based monitoring solutions. A true multifaceted partner to trial sponsors and Contract Research Organizations (CROs), Bioclinica offers a global network of research sites and patient recruitment services to provide committed, detail-focused service through all stages of drug development. The company's thousands of employees serve more than 400 pharmaceutical, biotechnology and device organizations – including all the top 20 biopharmaceutical companies and leading CROs – through a network of offices in the U.S., Europe, and Asia.

Learn more about Bioclinica and our Clinical Adjudication and other offerings at www.Bioclinica.com and in the Bioclinica Blog. Follow the latest company news and happenings on LinkedIn and Twitter.

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Medical Imaging of Non-Alcoholic Fatty Liver Diseases in Clinical Trials – Where Do We Stand?… https://t.co/zJJlrbyMAq
Bioclinica (21 hours ago)
Bioclinica's Electronic Data Capture #EDC has been used in thousands of clinical studies worldwide. Why? Our single… https://t.co/9IHk8a9NIZ
Bioclinica (4 days ago)
Is Your Study Supply Chain Management Solution Increasing the Risk of Stock Out Situations? https://t.co/zGMRSwAunZ… https://t.co/4BiypLB06k
Bioclinica (5 days ago)
Here are the five questions to ask your IRT vendor. https://t.co/JSc0RwKOyp #clinicaltrials #irt https://t.co/TbMgM8ull8
Bioclinica (6 days ago)
Over 25 years of experience, we offer world-renowned scientific expertise, regulatory leadership, and integrated te… https://t.co/owAFAqIHT7
Bioclinica (1 week ago)
Your trial needs Bioclinica experts who can see more deeply into essential imaging data. We offer expertise in… https://t.co/mNdCRkZYeI
Bioclinica (2 weeks ago)

Latest Blogs:

Medical Imaging of Non-Alcoholic Fatty Liver Diseases in Clinical Trials
EDC Provider Selection
Site Payments Solutions
Nonalcoholic steatohepatitis (NASH) development programs
Dr. Joby John
Transformational Trends in Investigator Site Payments
Clinical Supply Chain Success: Leveraging Technology
Blood pressure monitor
Prescription box